Non-Invasive Blood Glucose Monitoring Devices Market By Product Type (Self-Monitoring Blood Glucose Devices, Glucose Sstrips), Distribution Channel (Retail, Specialty Stores), End- User (Hospital and Home Healthcare) & Region for 2026-2032

Non-Invasive Blood Glucose Monitoring Devices Market Valuation - 2026-2032

Rising demand for non-invasive blood glucose monitoring devices consumers have been more aware of the benefits of blood glucose monitoring devices in recent years as the prevalence of diabetes has increased. During the pandemic, there was a significant increase in the use of virtual clinics and telemedicine to treat multiple illnesses including diabetes care. The hospital segment accounted for the highest proportion of the worldwide glucose monitoring devices market's end-user segment, as many patients are admitted due to severe diabetes and other concurrent conditions. The market size surpass USD 37.01 Million valued in 2024 to reach a valuation of around USD 324.93 Million by 2032.

Non-invasive blood glucose monitoring devices provide continuous, painless surveillance of a patient's glucose levels. Demand for smart diabetes management devices with advanced features is expected to boost the market. The rising demand for cost-effective and efficient non-invasive blood glucose monitoring devices is enabling the market grow at a CAGR of 31.20% from 2026 to 2032.

Non-Invasive Blood Glucose Monitoring Devices Market: Definition/ Overview

Blood glucose monitoring is the use of a glucose monitor to determine the level of glucose in the blood (glycemia). A blood glucose test, which is especially crucial in diabetes treatment, is commonly performed by piercing the skin (usually with a fingerstick) and drawing blood, which is then applied to a chemically active disposable.

Glucose monitoring devices are an essential tool for detecting the sugar level in the blood, and they come in various types, including glucose meters, testing strips, and lancets. With the help of these devices, people can easily test their blood glucose levels at home and make necessary adjustments to their therapy. This allows individuals and their doctors to identify high or low blood glucose levels and make necessary changes to their treatment plan. Glucose monitoring devices have revolutionized diabetes care by offering patients greater control over their health and reducing the risk of acute hypoglycemia or hyperglycemia.

Non-invasive blood glucose monitoring devices measure blood glucose levels in diabetic individuals. Non-invasive glucose monitoring involves measuring blood without piercing the skin or causing pain or trauma to the consumer, which is why non-invasive gadgets are so popular. Non-invasive detection of blood glucose concentration improves blood sugar control and the quality of life for diabetics. Furthermore, it is utilized to treat both Type 1 and Type 2 diabetic patients.

How will Rising Prevalence of Diabetes Affect Non-Invasive Blood Glucose Monitoring Market?

Rising Prevalence in non-invasive blood glucose monitoring market, Diabetes has grown more common around the world, which has a direct impact on the growth of the non-invasive blood glucose monitoring equipment market. If high blood sugar is not effectively controlled it can cause long-term harm to organs and tissues. Monitoring blood sugar levels has become critical for diabetes management since it gives patients and healthcare professionals an accurate view of overall blood sugar control over the previous 2-3 months.

The rising prevalence of diabetes is likely to drive the growth of the global non-invasive blood glucose monitoring devices market over the predicted period. The American Diabetes Association (ADA) recommends measuring HbA1c levels at least twice a year for patients who are meeting treatment objectives and have stable glycemic control, and quarterly for patients whose medication has changed or who are not meeting glycemic goals.

According to the International Diabetes Federation, roughly 520 million persons aged 20 to 79 had diabetes in 2021, and this figure is anticipated to climb to 700 million by 2045. Type 2 diabetes accounts for more than 90% of diabetes cases worldwide.

What are the Factors Restraining Demand for Non-Invasive Blood Glucose Monitoring Market?

The most significant factor is are expanding prevalence of non-invasive blood glucose monitor (NIBGM), it is a very new technology as compared to older finger-prick procedures. Accuracy and dependability are critical for diabetics in treating their condition. Currently, NIBGM devices may not always equal the precision of older methods, raising concerns among users who rely on extremely accurate data.

People with diabetes have established routines and are familiar with older procedures. Switching to a new technology, particularly one with potential accuracy issues can be scary. They may be cautious to adopt NIBGM unless they have trust in its accuracy and usability.

Non-Invasive blood glucose monitoring devices are typically more expensive than standard monitors. This can be a substantial hurdle for patients especially those with little financial resources or insufficient insurance coverage. The initial investment expense may make NIBGM less appealing for some.

Category-Wise Acumens

How the Segment Self-Monitoring Device will Dominate the Non-Invasive Blood Glucose Monitoring Devices Market?

The self-monitoring devices segment is substantially leading the non-invasive blood glucose monitoring devices market owing to the catering to individuals with diabetes who require regular monitoring of their blood sugar levels. This market includes a variety of self-testing products, such as glucose strips, glucose meters, and lancets. These devices enable diabetics to easily and accurately monitor their glucose levels at home, allowing them to make educated decisions regarding their diabetes treatment routine.

Glucose meters are booming the non-invasive blood glucose monitoring devices market, glucose meters are handheld electronic devices used to measure and display blood glucose levels based on the readings obtained from glucose strips. These meters play a critical role in self-monitoring blood glucose devices, providing users with real-time feedback on their glucose levels. The glucose meter segment is characterized by ongoing technological advancements aimed at improving accuracy, speed, and user-friendliness. Key features such as wireless connectivity, data storage, and compatibility with mobile apps are increasingly incorporated into glucose meters to enhance usability and convenience for individuals managing diabetes.

How will the Home Healthcare and Hospitals Segment Control the Non-Invasive Blood Glucose Monitoring Devices Market?

The home healthcare segment dominates the market for non-invasive blood glucose monitoring devices, the hospital segment is seeing significant growth opportunities due to increased adoption of advanced monitoring technologies and a growing emphasis on improving diabetes management in healthcare facilities.

Due to a number of factors, including an increase in the global prevalence of diabetes, a greater emphasis on patient-centered care, and a growing desire for convenient and accessible monitoring systems. Individuals with diabetes prefer the convenience and privacy of monitoring their blood glucose levels at home rather than frequent visits to healthcare institutions. Non-invasive blood glucose monitoring devices designed for home usage provide ease of use, portability, and real-time data tracking, empowering patients to efficiently manage their condition between healthcare consultations.

While the home healthcare segment leads the industry, the hospital segment is rapidly expanding and deemed thriving. Hospitals continue to be significant end users of non-invasive blood glucose monitoring devices, particularly for diabetes management in hospitalized patients and those requiring intensive care.

Country/Region-wise Acumens

How Does North America Emerge the Non-Invasive Blood Glucose Monitoring Devices Market?

North America emerges as the leading force in the projected market for non-invasive blood glucose monitoring devices, in 2019, North America led the global market for non-invasive blood glucose monitoring devices by revenue, followed by Europe. The region's huge market share can be due to its high disease prevalence and well-established healthcare infrastructure, which allows for accurate diagnosis. In 2018, the American Diabetes Association reported that 34.2 million people in the United States had diabetes, accounting for 10.5% of the population. Type 1 diabetes affects 1.6 million people, including around 187,000 children and adolescents.

North America's dominance in the predicted market for non-invasive blood glucose monitoring devices is due to excellent reimbursement policies, greater diabetes awareness, well-developed healthcare infrastructure, and a supportive regulatory environment. As these factors continue to drive demand and acceptance, North America is expected to maintain its dominance in the global market for non-invasive blood glucose monitoring devices.

Will Non-Invasive Blood Glucose Monitoring Devices Market Witness Rapid Growth in Asia Pacific?

The Asia Pacific market is poised to grow rapidly during the projected period, driven primarily by the rising prevalence of diabetes and increased knowledge about its diagnosis and treatment. This increase in diabetes prevalence is especially noticeable in Asia Pacific, where the majority of countries are experiencing rapid economic growth. As a result, many healthcare companies are making significant investments in the region to capitalize on the growing demand for non-invasive blood glucose monitoring devices and related technology. These collaborative efforts are critical in driving the market's growth throughout Asia Pacific.

According to data from the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in developing nations, owing to rapid and ongoing socioeconomic changes. This trend is projected to continue, driving up demand for non-invasive blood glucose monitoring devices in Asia Pacific.

As the region's economies mature and healthcare infrastructure improves, there is an increasing need to treat the rising diabetes burden. As a result, the combination of rising illness prevalence, increased awareness, and significant investments highlights the non-invasive blood glucose monitoring devices market's enormous growth potential in Asia Pacific.

Competitive Landscape

The non-invasive blood glucose monitoring devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the non-invasive blood glucose monitoring devices market include:

• DiaMonTech GmbH
• Nemaura Medical, Inc.
• Integrity Applications, Inc.
• CNOGA Medical Ltd.
• Breath Health, Inc.
• Metamaterial Technologies, Inc.
• Opticology, Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S
• Abbott (U.S.)
• GlySens Incorporated
• Novo Nordisk
• PHC Holdings Corporation
• TaiDoc Technology Corporation
• AgaMatrix
• Dexcom, Inc.

Latest Developments

• In May 2024, Abbott announced new programs aimed at increasing diversity in medical trials and improving care for underrepresented communities.
• In June 2024, Know Labs, a medical diagnostic business, plans to launch the first commercially available non-invasive glucose monitor, the Generation 1 gadget.

In May 2019, Nemaura got a CE mark for SugarBEAT, a non-invasive continuous glucose monitoring device, for sale in EU territories.Non-Invasive Blood Glucose Monitoring Devices Market, By Category

• Product Type:
• Self-Monitoring Blood Glucose Devices
• Glucose strips
• Glucose meter
• Lancets
• Continuous Glucose Monitoring Devices
• Distribution Channel:
• Retail
• Specialty Stores
• Drug Stores/Pharmacies
• Online
• End-User:
• Hospital
• Clinics
• Diagnostic Centers
• Home Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa